Cell Therapies welcomes CAR-T manufacturing announcement

Cell Therapies, a leader in the development, manufacturing and distribution of cell-based therapies, has welcomed an agreement with Novartis to produce their CAR-T cell therapy product KYMRIAH (tisagenlecleucel) in Melbourne. The agreement will enable the first Australian on-shore commercial manufacture and supply of this therapy. Currently, Australians who receive this immunotherapy have their blood collected […]